In conclusion, during the 10-year observation period, higher levels of serum RBP4, resistin, and PAI-1 were associated with the risk of developing prediabetes or type 2 diabetes and lower serum adiponectin level was a predictor of future prediabetes. Here, RBP4 is linked to prediabetes syndrome.